The Imovax Rabies market is witnessing steady growth over the forecast period, supported by increasing travel to rabies endemic regions, expansion of veterinary public health programs.
Read More
The Imogam market is witnessing steady growth over the forecast period, supported by increasing animal bite incidents, expansion of rabies awareness campaigns.
Read More
The Imlygic market is witnessing steady growth over the forecast period, supported by expansion of cancer immunotherapy pipelines, increased combination oncology trials.
Read More
The Imfinzi (durvalumab) market is witnessing steady growth over the forecast period, supported by expansion into new cancer indications, increased immunotherapy accessibility.
Read More
The Ilumya market is witnessing steady growth over the forecast period, supported by increasing biologic penetration in dermatology, growth in systemic psoriasis therapies.
Read More
The Ilaris market is witnessing steady growth over the forecast period, supported by expansion of precision immunology research, increasing diagnosis of rare inflammatory diseases.
Read More
The Idelvion market is witnessing steady growth over the forecast period, supported by increasing use of long acting factors, rising access to home infusion.
Read More
The Idefirix market is witnessing steady growth over the forecast period, supported by rising demand for kidney transplants, expansion of transplant waiting lists.
Read More
The Hyqvia market is witnessing steady growth over the forecast period, supported by rising diagnosis of primary immunodeficiency, expansion of home healthcare services.
Read More
The Hyprho-D market is witnessing steady growth over the forecast period, supported by growth in institutional deliveries, rising maternal healthcare spending.
Read More